Enhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in Japanese. [electronic resource]
- Drug metabolism and pharmacokinetics 2010
- 298-306 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1880-0920
10.2133/dmpk.25.298 doi
Aryl Hydrocarbon Hydroxylases--genetics Biotransformation--genetics Case-Control Studies Chemical and Drug Induced Liver Injury--epidemiology Cytochrome P-450 CYP2B6 Enzyme Activation--drug effects Genotype HLA Antigens--genetics Haplotypes--genetics Humans Japan--epidemiology Oxidoreductases, N-Demethylating--genetics Platelet Aggregation Inhibitors--adverse effects Polymorphism, Single Nucleotide Ticlopidine--adverse effects